We evaluated a template for molecular genetic test reports that was developed as a strategy to reduce communication errors between the laboratory and ordering clinician.
Don't forget—an American's odds of living a long and healthy life still depend more on his zip code than his genetic code. That won't change until we make healthcare more affordable, writes Dr. Arthur Kellermann.
With input from key stakeholders and building upon prior work, we created a template for molecular genetic test reports designed to improve clinical decision making at the point of care.
Appropriate use of existing diagnostic tests for infections, and development of better ones, could reduce overuse of antibacterial drugs.
The goal of this project was to assess genetic/genomic content in electronic health records.
This fact sheet summarizes recommendations for health care workers, consumers, and the scientific community to prepare the health care system for genomic medicine for common chronic diseases.
Although advances in genomic medicine for common adult chronic diseases such as heart disease, diabetes, and cancer hold promise for improved prevention, diagnosis and treatment, health professionals and the public are not prepared to effectively integrate these new tools into practice.
Synthesizes current information on genetic health services for common adult-onset conditions by examining studies that have addressed the outcomes, consumer information needs, delivery, and challenges in integrating these services.
Investigate the possibility that family history beyond early-onset coronary heart disease might contribute to coronary heart disease susceptibility, the authors studied associations between additional family history and the coronary artery calcium score.
Lipoprotein lipase hydrolyzes circulating triglycerides. 3'-end haplotypes in the LPL gene influence atherosclerosis and insulin resistance.
Women with asymptomatic LV systolic dysfunction may not achieve a mortality benefit when treated with ACE inhibitors.
The author warns that genomic medicine runs the risk of diverting the attention of medicine away from what the public and its critics have been saying
Affiliated Adjunct Staff
M.D., M.P.H., University of California, Los Angeles; B.S. in biology, University of California, Riverside